Infliximab is a monoclonal antibody, a human-mouse chimeric monoclonal antibody that inhibits TNF-alpha and prevents TNF-alpha from interacting with TNFR1 and TNFR2. Infliximab can be used to treat Crohns disease and rheumatoid arthritis.
Purity:
98.00%
CAS Number:
[170277-31-3]
Target:
TNF|||Antibacterial
T9921
T9921
* VAT and and shipping costs not included. Errors and price changes excepted